McCracken Brendan Michael reported grant involving 1,143 derivative units of Ovintiv Inc. at $0.00 for $0 on Sep 29, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
President & CEO
President & CEO
Filed Oct 1, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
1,143Restricted Share Unit
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
227,891Direct
Trade date
Sep 29, 2026Grant
Filed
Oct 1, 2026, 6:51 PM ET2-day reporting delay
Accession
0001788621-26-000013Code A · Transaction 233388
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

OVV price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
OVV · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +7.7%1w ago −1.9%1d ago −0.8%
Returns since7d +5.7%30d +21%90d180d1y

Footnotes in full

F1: Each Restricted Share Unit ("RSU'') is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs, subject to the grantee's continued employment with Ovintiv through the applicable exercise date. F2: Dividend equivalent RSUs received in lieu of cash dividends for the third quarter of 2026.